Court orders NY co to stop Canadian drugs

9 April 2006

The US District Court for the Southern District of New York has ordered a New York company run by Christine and Claire Ruggiero to stop importing drugs from Canada, receiving commissions from such importation and advertising or promoting any drug import service. The court also ordered the defendants to pay $4,000 in profits from their illegal activities.

The permanent injunction is the result of legal action begun in November 2004, when the federal government filed a civil complaint, based on a Food and Drug Administration investigation of Canada Care Drugs Inc's illegal importation operations. The FDA's investigation involved undercover purchases of prescription medicines through Canada Care. The law suit alleged the women earned a 10% commission from illegally importing the drugs, beginning in November 2003, from Canadian pharmacies that do not make the products and are not required to follow storage and delivery safeguards.

In announcing the ruling, the FDA stressed that illegally imported drugs can pose a public health risk because the quality, safety and effectiveness of the medicines cannot be assured.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight